Drugs & Targets FDA approves AstraZeneca’s Tagrisso for EGFR mutation-positive NSCLC March 31, 2017Vol.43 No.13
Drugs & Targets FDA approves niraparib for epithelial ovarian, fallopian tube, or primary peritoneal cancer March 31, 2017Vol.43 No.13
Drugs & Targets Gamida Cell receives EMA orphan drug designation for NiCord March 31, 2017Vol.43 No.13
Drugs & Targets Cota, Novartis form collaboration to advance real-world evidence in breast cancer therapies March 31, 2017Vol.43 No.13
Drugs & Targets Novartis CAR-T cell therapy for pediatric r/r B-cell ALL gets FDA Priority Review March 31, 2017Vol.43 No.13
Drugs & Targets BMS, Foundation Medicine form collaboration to identify predictive biomarkers across tumor types, immunotherapy agents March 31, 2017Vol.43 No.13
Drugs & Targets AbbVie, M2Gen announce collaboration for the ORIEN Avatar Research Program March 31, 2017Vol.43 No.13
In Brief Carlo Croce to receive 2017 AACR Margaret Foti Award for leadership, achievements in research March 31, 2017Vol.43 No.13
In Brief Roger Lo to receive AACR-Waun Ki Hong award for outstanding achievement in cancer research March 31, 2017Vol.43 No.13
